1. Home
  2. TECX vs PAMT Comparison

TECX vs PAMT Comparison

Compare TECX & PAMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TECX
  • PAMT
  • Stock Information
  • Founded
  • TECX 2019
  • PAMT 1980
  • Country
  • TECX United States
  • PAMT United States
  • Employees
  • TECX N/A
  • PAMT N/A
  • Industry
  • TECX
  • PAMT Trucking Freight/Courier Services
  • Sector
  • TECX
  • PAMT Industrials
  • Exchange
  • TECX Nasdaq
  • PAMT Nasdaq
  • Market Cap
  • TECX 334.4M
  • PAMT 301.4M
  • IPO Year
  • TECX 2018
  • PAMT 1985
  • Fundamental
  • Price
  • TECX $19.76
  • PAMT $16.37
  • Analyst Decision
  • TECX Buy
  • PAMT Hold
  • Analyst Count
  • TECX 6
  • PAMT 1
  • Target Price
  • TECX $72.40
  • PAMT $12.50
  • AVG Volume (30 Days)
  • TECX 203.0K
  • PAMT 42.1K
  • Earning Date
  • TECX 05-08-2025
  • PAMT 04-23-2025
  • Dividend Yield
  • TECX N/A
  • PAMT N/A
  • EPS Growth
  • TECX N/A
  • PAMT N/A
  • EPS
  • TECX N/A
  • PAMT N/A
  • Revenue
  • TECX N/A
  • PAMT $687,396,000.00
  • Revenue This Year
  • TECX N/A
  • PAMT $0.61
  • Revenue Next Year
  • TECX N/A
  • PAMT $10.29
  • P/E Ratio
  • TECX N/A
  • PAMT N/A
  • Revenue Growth
  • TECX N/A
  • PAMT N/A
  • 52 Week Low
  • TECX $1.40
  • PAMT $11.01
  • 52 Week High
  • TECX $61.07
  • PAMT $23.70
  • Technical
  • Relative Strength Index (RSI)
  • TECX 49.14
  • PAMT N/A
  • Support Level
  • TECX $17.56
  • PAMT N/A
  • Resistance Level
  • TECX $21.99
  • PAMT N/A
  • Average True Range (ATR)
  • TECX 1.96
  • PAMT 0.00
  • MACD
  • TECX 0.21
  • PAMT 0.00
  • Stochastic Oscillator
  • TECX 46.15
  • PAMT 0.00

About TECX Tectonic Therapeutic Inc. Common Stock

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

About PAMT PAMT CORP Common Stock

PAMT Corp is a holding company that is engaged in providing truckload dry van carriers transporting general commodities throughout the continental United States, as well as the Canadian provinces of Ontario and Quebec. It has one reportable segment being motor carrier.

Share on Social Networks: